This is a non-core endpoint: only basic statistics are computed.
Multiple myeloma
C3_MULT_MYELOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
995 |
4. Check minimum number of eventsNone |
995 |
5. Include endpointsNone |
995 |
6. Filter based on genotype QC (FinnGen only) |
961 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Multiple myeloma
based on the number of shared cases.
Similar with more cases:
- Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)
- Multiple myeloma, including Hilmo
- Liquid cancers, helper endpoint
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 961 | 425 | 536 |
| Unadjusted period prevalence (%) | 0.20 | 0.15 | 0.25 |
| Median age at first event (years) | 71.03 | 70.26 | 71.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 995
- Matched controls
- 9950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M04AA01
ATC
allopurinol; systemic
10.4
312.9
549
1055
H02AB02
ATC
dexamethasone; systemic
451.8
307.7
696
51
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
18.1
307.7
313
246
L03AA02
ATC
filgrastim; parenteral
1243.1
307.7
333
*
A04AA01
ATC
ondansetron; systemic, rectal
67.6
307.7
390
94
ZX112
NOMESCO Finland
Subcutaneous
127.2
307.7
211
21
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
307.7
946
*
329
Kela drug reimbursment
Lenalidomide
+∞
307.7
387
*
XW000
NOMESCO Finland
Bone marrow biopsy
62.5
307.7
483
148
L04AX04
ATC
lenalidomide; oral
+∞
307.7
534
*
C90.0
ICD-10 Finland
Multiple myeloma
4503599627370496.0
307.7
947
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
609.9
307.7
824
78
153
Kela drug reimbursment
Lenalidomid
+∞
307.7
562
*
AA1AA
NOMESCO Finland
Head X-ray examination
98.4
307.7
204
26
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
43.7
290.4
177
49
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
32.8
287.8
192
72
J05AB01
ATC
aciclovir; systemic
9.1
277.3
561
1237
N02AA05
ATC
oxycodone; systemic
9.1
269.5
498
991
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
23.5
267.5
204
108
WW500
NOMESCO Finland
Blood transfusion
26.4
266.7
193
90
B03XA02
ATC
darbepoetin alfa; parenteral
31.4
262.6
177
68
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
588.3
240.2
229
5
ZX120
NOMESCO Finland
Intravenous
11.5
236.3
287
339
L01AA03
ATC
melphalan; systemic
+∞
224.7
207
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.8
218.9
703
2337
WW300
NOMESCO Finland
Transfer of autologic stem cells
2463.0
201.0
188
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
566.5
193.5
186
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2331.0
193.2
181
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
59.2
188.1
106
20
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.3
185.6
218
242
B03XA01
ATC
erythropoietin; parenteral
40.9
168.1
103
28
393
Kela drug reimbursment
Pomalidomide
+∞
167.6
156
*
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
13.2
165.2
169
152
L04AX06
ATC
pomalidomide; oral
+∞
163.1
152
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.2
158.7
154
127
1507
Kela drug reimbursment
Pomalidomide
+∞
156.5
146
*
JN4AD
NOMESCO Finland
Body CT examination
9.4
156.1
210
276
ZX108
NOMESCO Finland
Inhalation
66.3
154.2
85
14
R50.9
ICD-10 Finland
Fever, unspecified
6.3
152.6
330
722
J05AB11
ATC
valaciclovir; oral
6.2
147.1
327
732
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
817.8
147.0
141
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
770.7
139.4
134
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.0
138.6
309
690
M05BA02
ATC
clodronic acid; systemic
1505.4
137.9
131
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
137.8
129
*
Z51.5
ICD-10 Finland
Palliative care
9.4
130.9
171
215
212
Kela drug reimbursment
Gout
13.1
126.3
127
110
L01AA01
ATC
cyclophosphamide; systemic
65.2
121.2
67
11
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
653.0
119.8
116
*
WW200
NOMESCO Finland
Immunization
15.4
119.4
108
78
A03FA01
ATC
metoclopramide; systemic, rectal
5.6
115.9
269
615
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.6
109.9
252
568
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.7
104.3
228
491
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
1096.6
103.1
99
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.2
102.6
148
208
B01AB05
ATC
enoxaparin; parenteral
3.9
98.9
491
1976
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
95.4
90
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.4
93.6
58
16
1XX32, ,
NOMESCO Finland
+∞
92.1
87
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.9
91.9
406
1496
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
41.5
90.5
55
14
5BA08, ,
NOMESCO Finland
37.0
89.4
56
16
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
247.0
89.0
90
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
926.7
88.1
85
*
398
Kela drug reimbursment
Ixazomib
+∞
85.7
81
*
WW409
NOMESCO Finland
Other aferesis
+∞
83.5
79
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
82.5
78
*
J01MA12
ATC
levofloxacin; systemic
3.9
82.2
334
1150
L04AX02
ATC
thalidomide; oral
855.4
81.7
79
*
1505
Kela drug reimbursment
Ixazomib
+∞
80.3
76
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
25.1
80.3
57
24
B01AB10
ATC
tinzaparin; parenteral
5.6
80.1
169
348
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.4
79.0
488
2187
E83.50
ICD-10 Finland
Hypercalcemia
17.5
76.8
64
39
TK800
NOMESCO Finland
Hemodialysis
12.4
76.6
78
68
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
76.0
72
*
WF004
NOMESCO Finland
Palliative radiotherapy
773.5
74.2
72
*
M05BX04
ATC
denosumab; parenteral
5.8
73.0
148
293
JN4BD
NOMESCO Finland
Extensive body CT
6.4
72.4
130
229
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.9
70.7
92
113
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
254.5
70.3
71
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.1
70.1
133
247
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
70.0
250
778
WW402
NOMESCO Finland
Leucoferesis
+∞
68.5
65
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
67.3
623
3439
B74
ICPC
Malignant neoplasm blood other
349.4
66.3
66
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.1
64.5
102
157
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
227.7
62.9
64
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
635.7
61.5
60
*
J01MA14
ATC
moxifloxacin; systemic
4.4
60.7
175
463
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
60.0
57
*
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
58.9
56
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
58.9
56
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
58.9
56
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
53.6
51
*
L03AA13
ATC
pegfilgrastim; parenteral
193.8
53.5
55
*
A04AA02
ATC
granisetron; systemic, transdermal
280.2
52.7
53
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
52.4
287
1150
NB6AA
NOMESCO Finland
Humerus X-ray examination
7.7
51.0
74
103
A02BC02
ATC
pantoprazole; systemic
3.0
49.7
762
5152
GD1AD
NOMESCO Finland
Thorax CT examination
5.2
47.8
105
221
C03CA01
ATC
furosemide; systemic
2.6
47.4
539
3111
ZX090
NOMESCO Finland
Other technic of radiotherapy
171.6
47.3
49
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
47.3
45
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.4
47.2
81
135
NF3AA
NOMESCO Finland
Femur X-ray examination
7.6
47.1
69
97
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
46.9
295
1267
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
44.9
185
620
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
44.1
42
*
L01XG03
ATC
ixazomib; oral
+∞
44.1
42
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
15.0
43.5
39
27
A79
ICPC
Malignancy NOS
435.4
42.5
42
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
42.0
40
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
13.0
41.1
40
32
L01XX50
ATC
[U] ixazomib
+∞
40.9
39
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.6
40.8
102
239
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
39.8
124
343
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
13.7
39.3
37
28
A06AD11
ATC
lactulose; oral
2.7
38.8
270
1207
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
+∞
38.8
37
*
GA5AA
NOMESCO Finland
Rib X-ray examination
65.7
38.4
44
7
127
Kela drug reimbursment
Transplant complication
14.5
38.4
35
25
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
202.7
38.1
39
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
37.7
36
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
85.5
37.1
41
5
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
370.2
36.2
36
*
116
Kela drug reimbursment
Prostate cancer
+∞
35.6
34
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.5
35.3
70
134
H02AB09
ATC
hydrocortisone; systemic
8.0
34.7
48
63
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.5
34.3
68
130
A41.9
ICD-10 Finland
Sepsis, unspecified
4.6
33.9
85
199
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
33.5
32
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
33.5
32
*
130
Kela drug reimbursment
Malignant tumour
+∞
32.5
31
*
115
Kela drug reimbursment
Breast cancer
+∞
32.5
31
*
N17.8
ICD-10 Finland
Other acute renal failure
8.9
32.4
41
48
N03AX16
ATC
[U] pregabalin
2.4
32.1
289
1443
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
327.1
32.0
32
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
327.1
32.0
32
*
WZC30
NOMESCO Finland
Teaching
3.0
32.0
164
619
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.2
31.6
48
70
WVA20
NOMESCO Finland
Medicine administration
6.5
31.1
52
84
JN4CD
NOMESCO Finland
Very extensive body CT
8.3
30.9
41
51
WF002
NOMESCO Finland
Radical radiotherapy
60.4
30.3
35
6
H02AB06
ATC
prednisolone; systemic
2.1
30.3
533
3479
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
30.1
104
308
PJA12
NOMESCO Finland
Sentinel node biopsy
311.4
30.0
30
*
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
+∞
29.3
28
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
29.3
28
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.6
28.3
55
103
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
28.3
27
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
28.1
159
631
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
28.0
406
2441
A05AA02
ATC
ursodeoxycholic acid; oral
9.4
27.5
33
36
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
27.2
26
*
1CX01, ,
NOMESCO Finland
+∞
27.2
26
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
27.2
26
*
EBA10
NOMESCO Finland
Operative extraction of tooth
3.3
26.9
110
362
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.6
26.8
65
148
N02AX02
ATC
tramadol; systemic, rectal
2.0
26.2
470
3037
A11CC03
ATC
alfacalcidol; systemic
5.5
25.8
51
97
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.9
24.5
128
485
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
24.4
483
3205
E85.9
ICD-10 Finland
Amyloidosis, unspecified
38.6
24.0
30
8
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
23.8
162
702
E85.89
ICD-10 Finland
Other amyloidosis
128.1
23.7
25
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.3
23.4
40
66
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
23.2
71
193
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.4
23.1
59
140
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
23.0
22
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
85.5
22.8
25
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
235.2
22.7
23
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
235.2
22.7
23
*
N05CF01
ATC
zopiclone; oral
2.0
22.5
387
2428
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
9.0
22.5
28
32
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
8.5
22.3
29
35
HA1AA
NOMESCO Finland
X-ray mammography
5.1
22.0
47
96
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.7
22.0
72
205
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
22.0
21
*
5BA03, ,
NOMESCO Finland
+∞
22.0
21
*
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
22.0
21
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.0
21.9
104
373
A06AH03
ATC
naloxegol; oral
19.4
21.4
32
17
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
+∞
20.9
20
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
20.9
20
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
20.9
20
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
20.9
149
659
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.9
20.8
38
67
L02AE02
ATC
leuprorelin; implant, parenteral
78.5
20.8
23
*
L02BG04
ATC
letrozole; oral
112.4
20.6
22
*
N18.8
ICD-10 Finland
Other chronic renal failure
4.3
20.6
55
135
D70.89
ICD-10 Finland
Neutropenic splenomegaly
19.3
20.0
30
16
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
19.9
19
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
19.9
19
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
19.9
19
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.6
19.7
32
50
L03AB05
ATC
interferon alfa-2b; parenteral
203.9
19.6
20
*
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.6
19.4
37
68
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
47.0
19.3
23
5
N19
ICD-10 Finland
Unspecified kidney failure
3.3
19.2
74
234
Z3231
NOMESCO Finland
Registered nurse
2.0
18.9
276
1620
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
18.8
18
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
18.8
18
*
L01FC01
ATC
daratumumab; parenteral
+∞
18.8
18
*
A07AA02
ATC
nystatin; oral
3.0
18.8
86
302
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
39.2
18.6
23
6
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
193.5
18.6
19
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
30.7
18.4
24
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
18.1
264
1545
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
53.6
18.0
21
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
17.9
328
2069
ZXD05
NOMESCO Finland
Urgent procedure
1.9
17.5
313
1956
SPAT1255
SPAT
Intravenous administration of medicine
2.8
17.4
94
361
NB4AA
NOMESCO Finland
Scapula X-ray examination
19.0
17.4
26
14
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.8
16.9
38
81
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
14.4
16.9
28
20
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.4
16.6
42
99
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.8
16.5
37
79
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
16.4
342
2233
A28
ICPC
Limited function/disability NOS
1.9
16.3
253
1506
306
Kela drug reimbursment
Erythropoietin and darbepoetin
34.0
15.8
20
6
1AA01, ,
NOMESCO Finland
+∞
15.7
15
*
3XA02, ,
NOMESCO Finland
+∞
15.7
15
*
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
15.7
15
*
Z51.0
ICD-10 Finland
Radiotherapy session
162.5
15.5
16
*
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
32.2
14.8
19
6
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.4
14.7
29
55
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.4
14.7
53
161
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
14.6
111
502
3060, ,
Kela drug reimbursment
+∞
14.6
14
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
14.6
14
*
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
+∞
14.6
14
*
L02BB03
ATC
bicalutamide; oral
+∞
14.6
14
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
152.1
14.5
15
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
152.1
14.5
15
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
14.2
284
1819
D70.82
ICD-10 Finland
Drug-induced neutropenia
43.1
14.1
17
*
ZX100
NOMESCO Finland
Oral
5.9
14.0
25
43
SPAT1088
SPAT
Blood transfusion
16.0
14.0
22
14
B02.9
ICD-10 Finland
Zoster without complication
2.5
13.8
89
373
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.2
13.7
55
179
ZX070
NOMESCO Finland
Intensity modified radiotherapy
76.2
13.6
15
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
13.6
13
*
1534, ,
Kela drug reimbursment
+∞
13.6
13
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
13.6
13
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
13.6
13
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
13.6
13
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
11.1
13.6
25
23
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
16.5
13.5
21
13
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
141.9
13.5
14
*
NA2AD
NOMESCO Finland
Thoracic spine CT examination
13.0
13.4
23
18
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.3
13.0
34
82
ZZR00
NOMESCO Finland
Flap of skin
19.3
12.9
19
10
WF099
NOMESCO Finland
Other radiotherapy
50.7
12.9
15
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.6
12.8
42
120
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
12.7
73
290
ZYC01
NOMESCO Finland
Remote contact by phone
2.9
12.6
61
221
NK6AN
NOMESCO Finland
Total body bone isotope imaging
32.5
12.6
16
5
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
12.5
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.5
12
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
12.5
12
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
12.5
12
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
12.5
12
*
Y77
ICPC
Malignant neoplasm prostate
131.6
12.5
13
*
6BA02, ,
NOMESCO Finland
131.6
12.5
13
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.0
12.4
56
195
L04AD01
ATC
ciclosporin; systemic
5.9
12.3
22
38
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
14.6
12.3
20
14
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.8
12.2
37
100
H02AB07
ATC
prednisone; oral
1.9
12.1
157
873
A07AA09
ATC
vancomycin; oral
4.9
12.0
26
54
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
11.9
225
1408
ZXE00
NOMESCO Finland
One hour or less
1.6
11.8
347
2444
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
5.9
11.8
21
36
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.0
11.8
52
179
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
11.3
11.6
21
19
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
11.5
161
917
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
11.5
69
280
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
121.4
11.4
12
*
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
121.4
11.4
12
*
HAC20
NOMESCO Finland
Total mastectomy
121.4
11.4
12
*
C10AA07
ATC
rosuvastatin; oral
0.5
11.4
132
2278
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
11.4
108
535
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.0
11.3
23
26
A40.8
ICD-10 Finland
Other streptococcal sepsis
5.0
11.2
24
49
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
12.9
11.2
19
15
ECB20
NOMESCO Finland
Oral alveoplasty
8.7
11.1
23
27
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
4.9
11.0
24
50
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
4.7
11.0
25
54
N02BF02
ATC
pregabalin; oral
2.7
11.0
61
238
HAB40
NOMESCO Finland
Wedge excision of mammary gland
18.0
10.7
16
9
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
60.7
10.6
12
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.1
10.5
28
69
L02BA01
ATC
tamoxifen; oral
111.2
10.4
11
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
10.4
10
*
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
+∞
10.4
10
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
10.4
10
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
10.4
10
*
ZX114
NOMESCO Finland
Intramuscular
5.5
10.4
20
37
R4110
NOMESCO Finland
Physiotherapy
1.7
10.4
248
1647
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.2
10.4
40
127
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
10.4
169
1009
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
9.7
10.3
20
21
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
23.6
10.3
14
6
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
23.6
10.3
14
6
A41.8
ICD-10 Finland
Other specified sepsis
4.0
10.2
29
75
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
40.5
10.0
12
*
A02BC01
ATC
omeprazole; systemic
1.6
9.7
284
1982
R4190
NOMESCO Finland
Nutritional therapy
4.2
9.7
25
60
J02AC03
ATC
voriconazole; systemic
55.5
9.7
11
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.9
9.5
28
74
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
9.4
56
226
L03AA04, ,
ATC
101.0
9.4
10
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
17.7
9.4
14
8
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
9.4
9
*
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
+∞
9.4
9
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
9.4
9
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
12.5
9.4
16
13
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.4
9.4
33
99
R80
ICD-10 Finland
Isolated proteinuria
8.1
9.4
20
25
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
21.9
9.4
13
6
Z2221
NOMESCO Finland
Medical doctor
1.6
9.2
228
1525
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
9.1
114
624
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.8
9.1
27
72
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
9.1
108
581
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
9.1
44
160
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
9.0
55
225
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
24.3
8.9
12
5
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
8.7
8.8
18
21
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.8
8.8
16
15
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
8.8
286
2040
A12AA04
ATC
calcium carbonate; oral
4.2
8.7
23
56
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.8
8.7
42
152
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
50.4
8.7
10
*
WZC15, ,
NOMESCO Finland
50.4
8.7
10
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
50.4
8.7
10
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
8.6
35
115
WX882
NOMESCO Finland
High dependency care
3.2
8.6
34
110
S42.3
ICD-10 Finland
Fracture of shaft of humerus
4.1
8.6
23
57
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.7
8.6
45
171
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.2
8.5
22
53
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
90.8
8.4
9
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
90.8
8.4
9
*
J01CA04
ATC
amoxicillin; systemic
1.5
8.4
706
6110
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.7
8.4
19
41
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.4
826
7417
JN4BG
NOMESCO Finland
Body MRI with high intensity magnet
+∞
8.3
8
*
NAR00
NOMESCO Finland
Complete excision of tumour of bone or cartilage of spine, unspecified
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
8.3
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.3
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.3
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
8.3
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.3
8
*
1XX45, ,
NOMESCO Finland
+∞
8.3
8
*
B73
ICPC
Leukaemia
+∞
8.3
8
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
8.3
8
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
8.3
8
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
8.3
44
168
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
9.5
8.3
16
17
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.3
8.2
21
50
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
14.6
8.2
13
9
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
8.2
77
381
B01AB04
ATC
dalteparin; parenteral
2.5
8.1
49
200
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.1
8.0
32
104
B01.9
ICD-10 Finland
Varicella without complication
22.2
8.0
11
5
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
8.0
46
183
N06DX01
ATC
memantine; oral
0.4
8.0
31
824
B03BA03
ATC
hydroxocobalamin; parenteral
2.1
8.0
78
391
WX892
NOMESCO Finland
Monitored bed care
2.0
8.0
82
419
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
7.9
91
484
D64.8
ICD-10 Finland
Other specified anaemias
3.6
7.9
25
70
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.0
7.9
34
116
UJF32
NOMESCO Finland
Coloscopy
1.6
7.8
237
1656
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
7.8
72
353
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
3.1
7.8
32
106
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.8
7.8
38
139
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
15.2
7.7
12
8
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
7.7
78
1422
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.7
7.7
39
146
A10AC01
ATC
insulin (human); parenteral
1.9
7.6
98
541
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.0
7.6
21
53
N18.0
ICD-10 Finland
End-stage renal disease
4.3
7.5
19
45
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.2
7.5
29
93
L57.0
ICD-10 Finland
Actinic keratosis
1.9
7.3
92
504
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
6.9
7.3
17
25
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.4
7.3
48
204
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
7.3
216
1499
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
7.3
7
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
7.3
7
*
GA5DA
NOMESCO Finland
Bilateral rib X-ray exmaination
+∞
7.3
7
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
+∞
7.3
7
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
7.3
7
*
20399
ICD-8 Finland
Multiple myeloma
+∞
7.3
7
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.2
7.3
19
46
C10AX09
ATC
ezetimibe; oral
0.5
7.3
56
1123
C10AC01
ATC
colestyramine; oral
3.2
7.2
27
85
D69.5
ICD-10 Finland
Secondary thrombocytopenia
30.2
7.2
9
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
30.2
7.2
9
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.4
7.1
25
75
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
8.0
7.1
15
19
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.2
7.0
18
43
R06AE07
ATC
cetirizine; oral
1.5
7.0
331
2532
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.0
6.9
19
48
J01FF01
ATC
clindamycin; systemic
1.5
6.9
232
1654
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.9
543
4555
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
6.8
65
324
TPX15
NOMESCO Finland
Removal of vascular injection port
40.3
6.8
8
*
ZY010
NOMESCO Finland
Hospital outpatient
2.8
6.8
33
121
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
16.8
6.8
10
6
WX402
NOMESCO Finland
General anaesthesia
1.7
6.7
126
781
WX704
NOMESCO Finland
Intubation
2.1
6.7
64
319
WX002
NOMESCO Finland
Sedation and analgesia
1.6
6.7
179
1213
V03AE01
ATC
polystyrene sulfonate; oral
3.8
6.7
20
54
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.7
156
1023
XQ848
NOMESCO Finland
Dermatological photography
3.1
6.7
27
89
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.2
6.6
54
253
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
12.3
6.6
11
9
B82
ICPC
Anaemia other/unspecified
2.7
6.5
35
135
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.4
6.5
43
184
X76
ICPC
Malignant neoplasm breast female
70.3
6.4
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
70.3
6.4
7
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
70.3
6.4
7
*
H26.3
ICD-10 Finland
Drug-induced cataract
7.5
6.4
14
19
J01DB01
ATC
cefalexin; oral
1.4
6.3
705
6242
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
6.3
179
1228
H02AB04
ATC
methylprednisolone; systemic
1.6
6.3
137
883
L02BG03
ATC
anastrozole; oral
+∞
6.3
6
*
E85.8
ICD-10 Finland
Other amyloidosis
+∞
6.3
6
*
3AA13, ,
NOMESCO Finland
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
6.3
6
*
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
W0X00
NOMESCO Finland
Estimation of continuous need for medical therapy
26.8
6.2
8
*
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
7.1
6.2
14
20
L04AA06
ATC
mycophenolic acid; systemic
4.0
6.2
17
43
E83.51
ICD-10 Finland
Hypocalcemia
7.7
6.1
13
17
OAB42, ,
SPAT
0.3
6.1
17
531
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
6.0
118
738
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
10.1
6.0
11
11
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.3
6.0
22
68
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
533
1000
10.33
309.72
4.7
1.9
1.66
1.77
%
1.59
505
864
433
327
22.67
307.65
19.6
1.5
10.85
10.64
g/l
0.15
412
279
489
345
26.91
307.65
18.5
1.5
7.05
7.65
g/l
6.51
478
297
310
246
17.85
307.65
21.7
1.5
0.25
0.03
g/l
2.20
293
223
448
316
24.97
307.65
19.5
1.5
2.60
3.09
g/l
11.16
437
269
450
283
28.20
307.65
18.1
1.5
7.35
0.54
g/l
29.92
395
234
489
345
26.91
307.65
18.4
1.5
3.55
3.76
g/l
0.51
478
298
681
275
76.30
307.65
21.2
1.5
149.35
36.89
mg/l
4.91
619
223
489
345
26.91
307.65
18.4
1.5
—
—
—
0
0
304
76
57.16
307.65
5.1
1.8
0.93
2.63
g/24h
1.13
161
37
604
438
33.55
307.65
10.4
2.1
13.24
11.03
g/l
3.44
568
398
626
775
20.08
307.65
12.5
2.5
226.27
241.23
u/l
2.58
612
715
512
351
28.99
307.65
4.9
1.3
0.50
1.14
g/l
7.73
410
315
228
91
32.21
307.65
5.3
4.5
214.46
518.54
iu/ml
0.49
52
13
697
677
32.04
307.65
22.1
1.6
67.41
66.78
g/l
0.71
682
595
680
275
75.95
307.65
21.2
1.5
255.19
45.92
mg/l
1.83
619
222
408
108
63.34
307.65
1.7
1.3
—
—
—
0
0
679
265
78.53
307.65
20.3
1.5
37.28
1.22
ratio
1.96
53
19
461
743
10.70
303.84
3.9
2.2
60.19
67.99
e9/l
4.19
358
582
298
273
15.16
294.48
21.9
1.5
37.21
37.08
g/l
0.11
279
226
280
235
16.19
291.52
22.8
1.5
0.01
0.00
g/l
0.95
265
213
547
1128
9.55
289.50
7.1
1.3
3.44
2.78
g/l
1.13
475
623
272
231
15.83
280.74
23.4
1.5
0.00
0.00
g/l
-0.00
265
212
491
1021
8.52
252.94
11.1
4.3
1.11
1.03
mmol/l
4.77
473
926
198
142
17.16
222.95
2.6
1.5
—
—
—
0
0
202
152
16.42
221.50
2.6
1.4
—
—
—
0
0
176
104
20.34
218.41
2.6
1.4
—
—
—
0
0
176
104
20.34
218.41
2.6
1.4
—
—
—
0
0
138
66
24.11
187.28
2.2
2.1
273.17
335.78
u/ml
—
6
9
616
2024
6.36
186.50
10.7
2.5
1586.30
8203.38
umol/l
4.46
597
1710
145
79
21.31
186.09
3.9
3.3
1.86
1.46
%
0.32
136
65
181
6
369.91
184.89
1.5
1.0
—
—
—
0
0
154
101
17.86
180.72
2.7
1.5
—
—
—
0
0
437
1099
6.31
176.91
7.1
2.2
0.81
0.82
mmol/l
3.04
427
998
294
529
7.47
166.63
2.4
1.6
—
—
—
0
0
125
63
22.55
165.59
2.8
1.4
—
—
—
0
0
126
68
21.07
161.95
2.8
1.4
—
—
—
0
0
160
137
13.73
161.18
1.4
1.1
78.64
22.36
u/l
9.19
151
121
158
8
234.34
156.97
1.2
1.4
—
—
—
0
0
178
187
11.37
156.63
1.4
1.5
—
—
—
0
0
117
77
17.09
136.26
1.5
1.2
146.56
113.10
u/ml
—
22
8
226
379
7.42
135.13
2.5
1.6
1.44
1.57
g/l
0.94
208
326
81
20
44.00
135.04
2.0
1.6
30.69
46.91
%
2.97
81
20
86
27
34.77
134.45
1.7
2.1
32.46
48.63
%
2.78
28
16
139
127
12.56
133.80
1.2
1.3
—
—
—
0
0
82
23
38.76
132.30
3.5
1.2
—
—
—
0
0
104
57
20.26
132.29
3.2
1.3
—
—
—
0
0
104
57
20.26
132.29
3.2
1.3
—
—
—
0
0
104
57
20.26
132.29
3.2
1.3
—
—
—
0
0
81
23
38.25
130.23
3.5
1.2
—
—
—
0
0
81
23
38.25
130.23
3.5
1.2
—
—
—
0
0
705
3203
5.12
129.02
18.5
5.1
2.68
2.97
%
2.80
684
2944
437
1383
4.85
128.70
3.4
1.8
—
—
—
0
0
706
3219
5.11
128.38
19.6
5.4
9.95
8.86
%
13.64
686
2964
85
30
30.89
128.08
3.4
1.2
—
—
—
0
0
85
30
30.89
128.08
3.4
1.2
—
—
—
0
0
103
60
19.03
127.28
3.9
3.5
60.26
56.27
%
0.69
94
47
248
488
6.44
126.30
8.9
3.6
0.78
0.76
%
0.04
210
128
707
3269
5.02
125.04
18.8
5.3
27.98
26.16
%
3.62
687
3019
113
82
15.42
124.70
1.7
1.1
—
—
—
0
0
249
510
6.18
121.32
9.0
3.7
0.11
0.05
%
0.93
209
119
697
3239
4.85
121.04
17.7
5.1
54.98
58.63
%
11.15
674
2992
105
77
15.13
115.03
4.1
2.3
—
—
—
0
0
285
690
5.39
114.95
10.1
5.3
13.25
11.19
mmol/l
2.95
272
650
716
3561
4.60
109.06
19.7
5.1
0.14
0.20
e9/l
22.99
660
3069
709
3509
4.55
108.53
19.2
5.0
1.48
1.79
e9/l
16.62
659
3050
61
11
59.01
108.38
2.2
1.0
—
—
—
0
0
377
1214
4.39
105.32
3.5
1.8
28.79
30.07
s
3.12
362
1164
671
3243
4.28
104.92
16.0
3.6
32.89
35.06
g/l
16.57
651
2969
105
5
234.42
103.70
10.2
1.2
—
—
—
0
0
162
251
7.51
103.02
1.9
1.2
—
—
—
0
0
739
3881
4.51
101.26
42.4
5.4
1.21
1.21
mmol/l
0.38
670
3302
730
3808
4.44
100.79
48.0
5.7
3.05
4.42
e9/l
65.51
678
3262
103
6
191.19
100.35
4.5
1.2
—
—
—
0
0
94
75
13.74
97.83
1.8
1.4
—
—
—
0
0
94
75
13.74
97.83
1.8
1.4
—
—
—
0
0
699
3610
4.15
96.07
19.0
3.6
10.00
12.17
umol/l
8.80
689
3360
80
50
17.31
95.11
1.2
1.0
—
—
—
0
0
327
1047
4.16
90.27
3.4
2.5
24.12
22.22
%
1.55
283
871
677
3541
3.85
88.44
32.5
4.9
1.21
1.21
mmol/l
0.24
657
3120
337
1121
4.03
87.88
3.3
2.4
2.09
2.27
g/l
7.27
322
1025
75
52
15.52
84.35
1.2
1.2
—
—
—
0
0
85
79
11.67
80.15
1.6
1.1
201.22
299.93
u/ml
1.20
45
41
344
1236
3.73
79.01
3.3
2.3
12.48
12.59
umol/l
0.10
331
1124
296
977
3.89
76.85
2.7
1.8
—
—
—
0
0
296
980
3.88
76.47
2.6
1.8
—
—
—
0
0
51
19
28.24
74.95
3.5
2.2
—
—
—
0
0
83
87
10.32
71.93
1.7
1.4
—
—
—
0
0
57
32
18.83
71.10
2.1
4.7
—
41.33
—
0
6
62
42
15.68
70.44
1.3
1.3
—
—
—
0
0
62
42
15.68
70.44
1.3
1.3
—
—
—
0
0
56
31
19.08
70.30
2.5
1.3
—
—
—
0
0
56
31
19.08
70.30
2.5
1.3
—
—
—
0
0
54
28
20.34
69.80
3.1
1.4
—
—
—
0
0
62
43
15.31
69.55
2.4
1.3
—
—
—
0
0
62
43
15.31
69.55
2.4
1.3
—
—
—
0
0
591
3156
3.15
67.91
7.8
2.3
—
—
—
0
0
507
2497
3.10
67.02
8.6
2.1
2.31
2.35
mmol/l
5.30
470
2037
230
727
3.81
62.42
7.8
2.1
5.10
8.75
umol/l
3.90
209
624
376
1622
3.12
61.78
7.5
2.1
—
—
—
0
0
66
67
10.48
58.36
1.7
1.6
—
—
—
0
0
142
329
4.87
58.08
2.4
1.7
3.41
1.92
ug/l
0.66
128
282
81
108
8.08
58.02
1.6
1.3
—
—
—
0
0
48
29
17.34
57.67
1.1
1.1
—
—
—
0
0
73
95
8.21
53.31
1.7
1.3
—
—
—
0
0
91
152
6.49
53.04
2.3
1.3
—
—
—
0
0
205
667
3.61
52.63
3.6
3.5
95.89
93.20
ng/l
0.13
184
569
56
5
118.55
52.36
1.1
1.2
—
—
—
0
0
137
340
4.51
51.24
4.5
1.8
—
—
—
0
0
39
20
20.25
50.44
1.6
2.0
—
—
—
0
0
66
82
8.55
50.02
1.6
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
117
261
4.95
49.85
3.4
2.5
0.31
0.37
u/ml
1.12
71
162
89
161
5.97
47.79
4.7
1.9
94.13
85.92
%
2.44
89
154
65
84
8.21
47.68
2.7
1.2
—
—
—
0
0
65
85
8.11
47.21
2.7
1.2
—
—
—
0
0
65
86
8.02
46.74
2.7
1.2
—
—
—
0
0
64
84
8.07
46.33
5.4
7.1
9.62
12.64
mg/l
4.82
57
79
65
87
7.92
46.29
2.7
1.2
—
—
—
0
0
65
87
7.92
46.29
2.7
1.2
—
—
—
0
0
408
2080
2.63
46.19
2.2
2.2
2.81
2.95
mg/l
0.52
344
1735
63
87
7.66
43.65
2.7
1.2
—
—
—
0
0
507
2926
2.49
43.39
3.8
2.7
332.56
135.29
ug/l
8.37
476
2632
681
4554
2.57
41.50
17.1
4.3
6.61
6.91
mmol/l
3.64
665
4265
45
45
10.43
40.05
1.4
1.5
—
—
—
0
0
153
492
3.49
39.36
5.6
3.7
0.74
2.02
mmol/l
3.25
112
356
160
531
3.40
39.16
2.4
1.7
—
—
—
0
0
341
1702
2.53
39.10
7.7
3.5
87.41
83.26
%
2.15
334
1647
208
812
2.97
38.64
7.5
3.0
1.29
2.08
mmol/l
1.87
173
681
134
402
3.70
38.26
2.1
1.3
4.29
2.81
ug/l
0.56
106
294
156
521
3.37
37.73
5.7
3.7
4.69
5.22
kpa
9.35
144
490
40
38
10.93
36.84
1.1
1.1
—
—
—
0
0
114
317
3.93
36.26
2.9
1.7
—
—
—
0
0
463
2744
2.29
35.07
4.1
3.1
—
—
—
0
0
55
85
6.79
34.37
1.4
1.3
—
—
—
0
0
471
2847
2.24
33.59
5.2
3.1
2265.43
1689.10
ng/l
2.00
436
2437
109
313
3.79
33.04
6.5
4.1
24.07
24.91
mmol/l
2.00
100
284
399
2269
2.27
32.86
4.2
3.1
48.58
86.98
e6/l
0.46
337
1743
141
492
3.17
31.49
1.7
1.5
—
—
—
0
0
294
1498
2.37
31.07
2.8
1.6
1.38
1.42
mg/l
0.06
245
1165
75
186
4.28
27.73
1.5
1.4
—
—
—
0
0
75
186
4.28
27.73
1.5
1.4
—
—
—
0
0
426
2624
2.09
27.38
5.0
3.6
64.33
119.42
e6/l
1.85
344
1876
357
2074
2.12
26.65
4.3
3.0
0.58
0.44
e6/l
0.64
297
1583
569
3937
2.04
26.15
17.7
19.8
1.30
1.40
inr
1.55
139
1112
735
5606
2.19
25.73
33.4
5.2
74.82
77.20
u/l
0.80
721
5126
110
372
3.20
25.73
9.2
3.3
23.42
24.20
mmol/l
1.43
110
358
363
2158
2.07
25.19
2.0
1.6
19.09
20.27
nmol/l
0.73
345
1790
234
1179
2.29
24.68
3.6
2.9
2.36
2.39
e6/l
0.02
129
646
29
31
9.61
24.50
1.8
1.3
16.85
13.82
ug/l
0.63
29
31
43
76
5.87
23.51
1.2
1.2
238.46
181.72
miu/ml
0.31
14
26
147
613
2.64
23.37
1.7
1.6
376.26
368.87
nmol/l
0.14
141
540
277
1523
2.13
23.36
6.3
2.2
2.49
2.45
mmol/l
2.57
253
1296
286
1602
2.10
22.91
3.1
2.4
6.89
4.86
e6/l
1.78
272
1427
39
66
6.11
22.28
1.2
1.2
—
—
—
0
0
237
1273
2.13
20.96
3.5
2.7
1.07
1.65
e6/l
0.97
133
737
148
654
2.48
20.75
7.2
5.4
1.29
1.51
mmol/l
1.85
143
639
316
1896
1.98
20.57
1.9
1.8
1039.69
1163.81
nmol/l
1.38
264
1410
32
50
6.58
19.74
1.7
1.5
—
—
—
0
0
24
6
40.98
19.56
1.3
1.2
—
—
—
0
0
23
6
39.21
18.61
1.4
1.0
—
—
—
0
0
280
1661
1.95
18.53
6.4
4.2
151.01
408.24
ng/l
2.20
247
1421
324
2049
1.86
17.46
6.2
2.5
35.31
33.96
u/l
0.12
307
1939
185
969
2.12
17.16
6.7
5.7
0.82
1.31
mmol/l
0.55
136
747
56
161
3.63
16.84
2.6
2.4
1.93
1.74
mg/l
0.60
48
139
183
962
2.11
16.79
6.8
5.7
11.66
11.15
kpa
0.76
171
911
183
962
2.11
16.79
6.9
5.7
4.86
5.06
kpa
1.18
170
913
45
112
4.16
16.54
1.2
1.1
—
—
—
0
0
71
241
3.10
16.42
2.4
3.2
—
—
—
0
0
157
788
2.18
16.19
7.4
6.3
103.84
121.40
g/l
21.13
150
770
638
4996
1.77
16.12
6.2
4.8
17.64
2403.92
e6/l
2.02
11
83
348
2313
1.78
15.56
2.8
2.2
56.59
60.66
u/l
0.72
331
2111
52
152
3.55
15.27
1.8
1.7
13.98
14.61
u/ml
0.07
44
120
88
354
2.63
14.88
7.2
4.2
1.54
1.76
%
0.96
82
338
22
12
18.71
14.73
3.7
1.1
—
—
—
0
0
488
3620
1.68
14.32
2.7
2.1
87.18
93.03
pmol/l
2.35
349
1808
630
7439
0.58
14.15
4.2
5.5
2.49
2.58
mmol/l
1.38
575
6699
456
3337
1.68
13.98
5.7
4.2
43.45
72.80
ng/l
1.14
404
2551
678
5511
1.72
13.88
8.2
4.2
37.65
13.66
mm/h
55.76
646
5002
60
204
3.07
13.84
1.6
1.5
0.24
0.23
g/l
0.25
54
196
61
210
3.03
13.78
1.6
1.5
1.15
1.15
g/l
0.07
56
199
24
21
11.68
13.34
1.2
1.1
—
—
—
0
0
17
6
28.78
12.98
1.8
1.7
—
—
—
0
0
70
269
2.72
12.94
1.2
2.0
34.18
38.98
u/l
1.03
62
226
453
3376
1.63
12.47
3.4
2.3
—
—
—
0
0
422
3105
1.62
12.14
2.6
2.2
82.70
79.37
nmol/l
1.62
394
2657
38
110
3.55
11.35
1.2
1.3
—
—
—
0
0
39
115
3.49
11.33
7.8
2.9
50.38
59.50
%
3.10
39
115
38
111
3.52
11.20
7.6
2.7
2.72
4.48
e9/l
5.56
38
111
20
19
10.72
10.80
1.1
1.3
—
—
—
0
0
623
7236
0.63
10.74
3.9
4.8
4.33
4.45
mmol/l
1.87
576
6538
21
40
5.34
10.62
1.5
1.3
—
—
—
0
0
615
7151
0.63
10.47
3.8
4.8
1.34
1.45
mmol/l
9.27
563
6420
113
1991
0.51
10.28
1.5
1.6
1.48
1.33
mmol/l
1.39
106
1640
84
398
2.21
9.90
8.0
7.2
23.21
24.39
mmol/l
1.43
78
381
20
39
5.21
9.86
1.1
1.2
—
—
—
0
0
22
30
7.47
9.73
1.0
1.0
—
—
—
0
0
49
184
2.75
9.51
8.7
6.0
105.53
105.43
mmol/l
0.04
43
169
21
28
7.64
9.44
2.0
2.0
705.05
1284.25
u/ml
0.69
21
28
147
867
1.82
9.33
3.9
3.2
256.88
241.53
ng/l
0.15
134
801
645
7334
0.66
8.64
5.3
5.1
6.08
6.11
mmol/l
0.22
584
6525
68
323
2.19
7.98
3.1
2.3
361.26
1200.58
ug/l
0.71
63
300
106
594
1.88
7.89
2.6
2.1
38.99
40.21
u/l
0.05
89
477
103
572
1.89
7.89
2.1
1.8
0.20
0.20
g/l
0.18
97
513
621
7074
0.68
7.87
5.5
6.6
40.90
41.17
mmol/mol
0.29
574
6440
81
415
2.04
7.82
2.5
2.5
0.36
0.26
e6/l
0.42
81
404
14
13
10.90
7.81
1.4
1.3
—
—
—
0
0
16
20
8.11
7.61
1.1
1.0
—
—
—
0
0
41
159
2.65
7.52
1.4
2.3
28.64
34.00
umol/l
0.92
33
145
7
0
+∞
7.30
1.9
0.0
—
—
—
0
0
611
6920
0.70
6.82
4.1
4.3
1.35
1.27
mmol/l
1.98
557
6133
36
140
2.63
6.59
1.4
1.7
—
—
—
0
0
100
583
1.80
6.57
6.3
6.2
23.75
24.45
mmol/l
0.76
92
558
17
30
5.75
6.47
4.2
1.4
9.15
3.92
nmol/l
0.56
17
30
17
30
5.75
6.47
1.6
1.4
—
—
—
0
0
17
30
5.75
6.47
1.6
1.4
—
—
—
0
0
14
19
7.46
6.42
1.1
1.1
743.36
1665.63
miu/ml
1.54
14
19
10
7
14.41
6.40
10.4
8.4
5.04
4.84
mmol/l
—
10
7
26
86
3.08
6.38
1.4
1.3
—
—
—
0
0
17
31
5.56
6.31
1.4
1.1
42.00
20.62
u/l
0.80
17
26
18
47
3.88
6.28
1.0
1.1
—
98.75
—
0
8
26
87
3.04
6.26
1.3
1.4
1230.05
2036.15
e6/l
0.80
19
62
16
40
4.05
5.91
1.1
1.4
—
—
—
0
0
27
97
2.83
5.76
1.1
1.3
—
—
—
0
0
42
191
2.25
5.54
1.4
1.4
239.48
298.24
ug/g
1.21
27
110
17
37
4.66
5.50
1.4
1.1
122.94
97.29
u/l
0.27
17
31
8
5
16.12
5.41
2.3
1.0
18.65
19.88
u/ml
—
8
5
443
3695
1.36
5.27
4.1
4.0
0.00
0.01
estimate
0.80
73
617
15
30
5.06
5.26
9.6
1.3
202.40
203.77
u/l
0.04
15
30
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
438
3651
1.36
5.21
5.8
5.3
0.00
0.00
estimate
-0.00
72
621
8
6
13.43
5.08
1.1
1.0
—
—
—
0
0
37
167
2.26
4.99
3.5
2.5
13.62
16.12
%
4.29
23
85
437
3664
1.34
4.91
4.1
3.9
0.00
0.01
estimate
0.96
80
692
44
215
2.09
4.90
6.4
2.9
1.44
1.67
mmol/l
1.36
44
207
7
5
14.08
4.58
1.3
1.4
—
—
—
0
0
9
11
8.24
4.56
1.8
1.3
—
—
—
0
0
9
11
8.24
4.56
1.0
1.0
—
—
—
0
0
102
678
1.56
4.11
2.1
2.1
125.98
181.31
ug/g
1.22
85
531
40
203
2.01
4.07
6.9
3.0
7.68
7.83
mmol/l
0.10
40
195
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
14
6.48
3.99
1.2
2.3
249.44
188.50
%
—
9
14
30
138
2.21
3.92
1.3
1.4
—
—
—
0
0
20
76
2.67
3.91
1.1
1.2
3.00
6.82
u/ml
—
6
38
317
2637
1.30
3.48
2.4
2.2
153.06
252.21
u/l
1.91
302
2452
43
237
1.85
3.48
2.6
3.3
0.77
0.82
nmol/l
0.33
29
185
36
188
1.95
3.42
3.4
2.1
107.70
131.72
g/l
6.62
27
140
21
88
2.42
3.41
2.7
3.3
—
—
—
0
0
5
193
0.26
3.41
1.0
1.4
—
—
—
0
0
19
76
2.53
3.39
1.1
1.1
1.00
2.76
u/ml
—
5
21
37
197
1.91
3.33
1.3
1.5
0.13
0.12
iu/ml
—
10
48
19
79
2.43
3.15
1.4
1.5
14818.78
113053.59
e6/l
—
9
44
27
131
2.09
3.14
7.6
1.9
52.31
64.84
%
1.90
27
131
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
35
3.46
3.11
1.0
1.1
—
—
—
0
0
28
144
1.97
2.82
1.1
1.1
—
—
—
0
0
11
33
3.36
2.81
1.0
1.1
—
—
—
0
0
11
34
3.26
2.73
1.0
1.0
—
—
—
0
0
8
217
0.36
2.68
1.1
1.4
—
—
—
0
0
35
198
1.80
2.67
1.2
1.1
—
—
—
0
0
8
21
3.83
2.46
1.5
1.2
—
—
—
0
0
34
197
1.75
2.42
1.2
1.1
—
—
—
0
0
634
6787
0.82
2.37
4.8
4.7
2.15
2.21
mu/l
0.12
595
6045
465
4181
1.21
2.34
3.7
2.9
62.75
48.66
u/l
2.51
443
3776
84
1133
0.72
2.24
13.7
7.4
—
—
—
0
0
107
812
1.36
2.23
4.9
3.2
—
—
—
0
0
12
48
2.52
2.19
1.3
1.7
16.15
15.06
umol/l
0.13
12
42
763
7993
0.81
2.16
83.2
21.2
114.73
134.27
g/l
157.45
747
7791
763
7992
0.81
2.15
82.7
21.1
3.68
4.43
e12/l
162.06
740
7650
763
7991
0.81
2.14
82.8
21.1
188.39
240.88
e9/l
66.55
741
7687
10
36
2.80
2.14
1.1
1.2
—
—
—
0
0
763
7990
0.81
2.13
82.6
21.1
34.61
39.65
%
79.64
688
7239
21
109
1.95
2.11
6.7
5.5
6.24
7.73
mmol/l
1.97
16
90
7
20
3.52
2.05
1.0
1.2
—
—
—
0
0
20
104
1.94
2.01
1.5
1.9
89.02
89.65
%
0.12
20
104
7
21
3.35
1.96
1.0
1.1
—
—
—
0
0
7
21
3.35
1.96
1.0
1.1
—
—
—
0
0
94
715
1.35
1.95
1.3
1.3
—
—
—
0
0
5
11
4.56
1.94
1.0
1.2
—
—
—
0
0
9
33
2.74
1.93
1.0
1.2
—
—
—
0
0
7
22
3.20
1.88
1.0
1.2
—
—
—
0
0
24
137
1.77
1.84
1.2
1.3
—
—
—
0
0
31
191
1.64
1.83
1.6
1.6
—
—
—
0
0
7
23
3.06
1.80
1.0
1.2
—
—
—
0
0
761
7252
1.21
1.79
64.8
14.5
21.53
25.34
mg/l
3.30
730
5728
33
209
1.60
1.75
1.7
1.6
21666.81
13215.42
e6/l
0.55
21
154
39
259
1.53
1.70
1.2
1.2
—
—
—
0
0
0
48
0.00
1.70
0.0
1.5
—
—
—
0
0
17
90
1.90
1.66
1.8
1.4
—
—
—
0
0
8
32
2.51
1.60
2.8
3.8
—
—
—
0
0
6
20
3.01
1.58
1.0
1.1
—
—
—
0
0
35
232
1.53
1.56
1.4
1.3
—
—
—
0
0
51
368
1.41
1.50
2.3
2.2
11.79
14.81
nmol/l
1.45
44
320
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
110
894
1.26
1.45
2.4
2.6
5.81
7.14
ug/l
0.33
92
767
14
74
1.90
1.39
2.1
2.1
0.20
2.00
u/field
—
5
25
6
23
2.62
1.37
1.0
1.0
—
—
—
0
0
251
2813
0.86
1.34
3.2
3.8
21.44
8.07
mg/mmol
2.63
194
1775
14
75
1.88
1.34
1.1
1.1
—
—
—
0
0
648
6794
0.87
1.34
50.0
13.5
66.02
72.26
ml/min/173m2
7.82
576
5448
14
76
1.85
1.30
1.1
1.1
—
—
—
0
0
11
55
2.01
1.27
2.1
2.2
—
—
—
0
0
241
2690
0.86
1.21
2.8
3.1
6.67
7.17
mmol/l
1.08
212
2241
747
7733
0.86
1.20
41.4
9.3
25.86
24.35
u/l
1.34
733
7328
0
33
0.00
1.16
0.0
1.6
—
—
—
0
0
5
20
2.51
1.15
1.0
1.2
—
—
—
0
0
154
1336
1.18
1.10
1.2
1.2
1.67
1.94
u/ml
—
7
340
27
190
1.43
0.97
3.9
3.5
25.63
27.55
mg/l
0.14
19
123
290
2663
1.13
0.94
8.9
3.2
9924.04
153.89
mg/l
16.18
236
1699
7
37
1.90
0.94
3.0
2.4
—
—
—
0
0
16
102
1.58
0.91
1.5
3.0
27.20
25.25
mg/l
—
5
24
759
7805
0.88
0.90
66.0
17.9
3.98
4.01
mmol/l
2.41
746
7549
8
43
1.87
0.87
1.0
1.1
—
—
—
0
0
758
7786
0.89
0.84
58.8
17.8
138.71
139.74
mmol/l
20.61
745
7538
54
663
0.80
0.82
1.3
1.4
—
—
—
0
0
16
106
1.52
0.79
1.2
1.4
72.14
68.90
%
—
7
68
0
25
0.00
0.79
0.0
1.2
—
9.49
—
0
25
8
48
1.67
0.79
1.0
1.1
—
—
—
0
0
8
48
1.67
0.79
1.0
1.1
—
—
—
0
0
12
75
1.61
0.75
1.0
1.1
—
—
—
0
0
5
26
1.93
0.70
1.2
1.3
—
—
—
0
0
5
29
1.73
0.64
1.0
1.9
16.38
16.50
nmol/l
—
5
21
25
325
0.76
0.63
1.6
1.8
—
—
—
0
0
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
8
49
1.64
0.62
1.0
1.1
—
—
—
0
0
8
50
1.60
0.61
2.5
2.6
—
—
—
0
0
47
560
0.83
0.58
1.3
1.6
1.39
1.61
%
1.62
38
462
22
168
1.32
0.55
1.9
1.6
—
—
—
0
0
21
160
1.32
0.54
1.0
1.3
17.63
59.19
e6/l
0.59
16
133
21
160
1.32
0.54
1.0
1.4
16.06
945.57
e6/l
0.81
16
136
6
40
1.50
0.51
1.0
1.3
126.62
169.77
pmol/l
—
6
40
9
64
1.41
0.51
1.1
1.5
—
227.00
—
0
10
14
101
1.39
0.49
1.6
1.8
187.86
217.95
pmol/l
0.40
14
95
29
236
1.24
0.47
1.3
1.9
—
—
—
0
0
9
127
0.71
0.43
1.1
1.4
—
—
—
0
0
67
595
1.14
0.42
4.7
2.3
50.64
61.18
ml/min/173m2
1.56
39
244
18
140
1.29
0.42
1.6
1.8
2.02
5.13
iu/l
—
6
47
7
103
0.68
0.39
1.4
1.2
0.86
0.67
nmol/l
—
7
95
159
1689
0.93
0.35
2.8
2.7
0.86
0.75
ug/l
0.56
122
1178
6
86
0.70
0.33
1.2
1.0
—
—
—
0
0
237
2477
0.94
0.32
3.7
3.8
21.45
24.64
%
2.34
119
1209
293
2823
1.05
0.30
4.6
4.2
—
—
—
0
0
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
10
78
1.28
0.24
1.4
1.4
170.86
64.04
pmol/l
—
10
78
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
31
344
0.90
0.20
1.2
1.2
144.84
104.37
iu/ml
0.22
12
129
104
1093
0.95
0.19
1.2
1.3
17.99
12.49
u/ml
0.19
20
389
118
1133
1.05
0.16
1.2
1.3
32.12
41.01
iu/ml
0.22
34
356
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
5
45
1.11
0.10
1.2
1.2
0.02
0.90
u/ml
—
5
27
5
48
1.04
0.09
1.8
1.7
85.40
96.06
umol/l
—
5
48
198
2017
0.98
0.09
4.7
4.3
0.00
0.00
estimate
-0.00
55
604
8
74
1.08
0.07
1.0
1.1
—
73.10
—
0
10
107
1045
1.03
0.07
3.3
5.0
32.61
33.32
%
0.24
80
673
171
1737
0.98
0.06
4.3
4.3
1.02
1.02
kg/l
0.45
32
272
18
168
1.07
0.06
1.2
1.2
—
—
—
0
0
17
162
1.05
0.02
1.2
1.2
—
10.48
—
0
10
306
3049
1.01
0.01
4.3
4.0
2.45
2.06
ug/l
1.04
265
2698
605
6043
1.00
0.00
71.2
16.6
16.17
15.38
%
3.58
594
5892
194
1946
1.00
0.00
1.7
1.7
435.46
24043796.80
pmol/l
1.74
166
1568
554
5546
1.00
0.00
3.9
3.8
14.89
15.11
pmol/l
1.12
521
4923
26
264
0.98
0.00
1.1
1.0
—
—
—
0
0
17
167
1.02
0.00
1.3
1.5
—
—
—
0
0
19
187
1.02
0.00
1.4
1.2
—
3.06
—
0
22
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2.00
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
23.62
—
0
6
0
5
0.00
-0.00
0.0
1.8
—
12.00
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MULT_MYELOMA – Multiple myeloma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).